Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) EBT (2016 - 2025)

Sanara MedTech's EBT history spans 15 years, with the latest figure at -$782576.0 for Q4 2025.

  • For Q4 2025, EBT fell 180.57% year-over-year to -$782576.0; the TTM value through Dec 2025 reached -$4.9 million, down 8.21%, while the annual FY2025 figure was -$393124.0, 79.19% up from the prior year.
  • EBT reached -$782576.0 in Q4 2025 per SMTI's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.1 million in Q3 2025 to a low of -$4.2 million in Q4 2022.
  • Average EBT over 5 years is -$1.8 million, with a median of -$1.8 million recorded in 2024.
  • Peak YoY movement for EBT: plummeted 317.11% in 2021, then skyrocketed 853.58% in 2025.
  • A 5-year view of EBT shows it stood at -$3.6 million in 2021, then dropped by 17.06% to -$4.2 million in 2022, then soared by 93.7% to -$262444.0 in 2023, then surged by 470.09% to $971284.0 in 2024, then plummeted by 180.57% to -$782576.0 in 2025.
  • Per Business Quant, the three most recent readings for SMTI's EBT are -$782576.0 (Q4 2025), $1.1 million (Q3 2025), and -$1.8 million (Q2 2025).